Comparison Chart Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.990 USD | -1.48% |
|
-6.70% | -32.09% |
| May. 07 | Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026 | |
| May. 06 | Vanda Pharmaceuticals Inc. Raises Revenue Guidance for the Full-Year 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VANDA PHARMACEUTICALS INC. | Bio Therapeutic Drugs | -1.48% | -6.70% | -32.09% | +38.98% | -67.27% | 360M |  |  |  |
- Stock Market
- Equities
- VNDA Stock
- Charts Vanda Pharmaceuticals Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
